Immunome Inc

NASDAQ:IMNM  
5.19
+0.02 (+0.39%)
Earnings Announcements

Immunome Reports Q2 Net Loss Per Share Common Stock of $0.74

Published: 08/05/2022 12:28 GMT
Immunome Inc (IMNM) - Immunome Reports Second Quarter 2022 Financial Results.
Qtrly Net Loss per Share of Common Stock, Basic and Diluted $0.74.
As of June 30, 2022, Cash and Cash Equivalents Totaled $34.6 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.81

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.66

More details on our Analysts Page.